» Articles » PMID: 34164493

Protective Effect of Anisodamine on Bleomycin-induced Acute Lung Injury in Immature Rats Via Modulating Oxidative Stress, Inflammation, and Cell Apoptosis by Inhibiting the JAK2/STAT3 Pathway

Overview
Journal Ann Transl Med
Date 2021 Jun 24
PMID 34164493
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pediatric acute lung injury (ALI) is one of the most common causes of infant mortality. Although lung-protective strategies have developed in recent years, no ALI treatment is currently available. Anisodamine (Ani) is a common drug used to treat gastrointestinal smooth muscle spasm. The protective effects of Ani against acute kidney injury and myocardial injury have been reported. However, the efficacy of Ani on bleomycin (BLM)-induced ALI has not been examined previously. In the present study, we aimed to examine the effects of Ani on bleomycin (BLM)-induced ALI on immature rats.

Methods: The ALI rat model was established by intratracheally administration of BLM. Ani treatment was performed by an intravenous injection at different concentrations. The lung function of each rat was measured, and then lung tissue structures, apoptosis, and collagen deposition were observed by hematoxylin-eosin staining, terminal deoxynucleotidyl transferase-mediated digoxigenin-dUTP nick-end labeling assay, and Masson's staining, respectively. Enzyme-linked immunosorbent assay was used to detect the levels of inflammatory cytokines. The expression of apoptosis-related proteins and fibrosis-related markers was determined by reverse transcription-polymerase chain reaction and/or Western blot analysis. Finally, the expression levels of Janus tyrosine kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) were determined.

Results: Our findings indicated that lung function was remarkably decreased in BLM-induced rats, which could be reversed by Ani. Ani treatment increased the levels of antioxidant enzymes, decreased the apoptotic rate and apoptosis-related proteins, and downregulated the expression of fibrosis-related markers. Additionally, Ani treatment also attenuated inflammatory response and suppressed the activation of the JAK2/STAT3 pathway.

Conclusions: Our results demonstrated that Ani had potent activity against BLM-induced ALI in immature rats through inhibiting the JAK2/STAT3 signaling pathway. Our findings provide supporting evidence to further investigate the therapeutic effect of Ani against ALI in children.

Citing Articles

Study on the In Vitro and In Vivo Antioxidant Activity and Potential Mechanism of L.

Yang Z, Man J, Liu H, Wu D, Gu Q, Zhang H Antioxidants (Basel). 2025; 14(1).

PMID: 39857375 PMC: 11762547. DOI: 10.3390/antiox14010041.


Insights into Disease Progression of Translational Preclinical Rat Model of Interstitial Pulmonary Fibrosis through Endpoint Analysis.

Kadam A, Schnitzer J Cells. 2024; 13(6.

PMID: 38534359 PMC: 10969066. DOI: 10.3390/cells13060515.


Effect of trimetazidine against ovarian ischemia/reperfusion injury in rat model: A new pathway: JAK2/STAT3.

Yuksel T, Halici Z, Cadirci E, Toktay E, Ozdemir B, Bozkurt A Iran J Basic Med Sci. 2023; 26(11):1370-1379.

PMID: 37886007 PMC: 10598820. DOI: 10.22038/IJBMS.2023.72544.15776.


Luteolin Enhances Transepithelial Sodium Transport in the Lung Alveolar Model: Integrating Network Pharmacology and Mechanism Study.

Chen L, Yu T, Zhai Y, Nie H, Li X, Ding Y Int J Mol Sci. 2023; 24(12).

PMID: 37373270 PMC: 10299022. DOI: 10.3390/ijms241210122.


Cyanidin-3-O-glucoside plays a protective role against renal ischemia/ reperfusion injury via the JAK/STAT pathway.

Xiong Y, Jian J, Yu H, Wu J, Mao H, Feng R Acta Cir Bras. 2023; 38:e381023.

PMID: 37132754 PMC: 10158851. DOI: 10.1590/acb381023.


References
1.
Lei J, Wei Y, Song P, Li Y, Zhang T, Feng Q . Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress. Eur J Pharmacol. 2017; 818:110-114. DOI: 10.1016/j.ejphar.2017.10.029. View

2.
Owais K, Huang T, Mahmood F, Hubbard J, Saraf R, Bardia A . Cardiopulmonary Bypass Decreases Activation of the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway in Diabetic Human Myocardium. Ann Thorac Surg. 2015; 100(5):1636-45. DOI: 10.1016/j.athoracsur.2015.05.013. View

3.
Zhou Y, Sun Y, Hou W, Ma L, Tao Y, Li D . The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro. Int J Mol Med. 2020; 46(1):191-200. PMC: 7255460. DOI: 10.3892/ijmm.2020.4592. View

4.
Sahu B, Narota A, Naura A . Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib, prevents acute lung injury associated cognitive deficits potentially through suppression of inflammatory response. Eur J Pharmacol. 2020; 877:173091. DOI: 10.1016/j.ejphar.2020.173091. View

5.
Mou F, Mou C . Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis. Med Sci Monit. 2020; 26:e919739. PMC: 7020761. DOI: 10.12659/MSM.919739. View